Thermo Fisher's Wild Ride: Rebound or False Dawn?

Is Thermo Fisher Scientific a buy? The life science giant's stock has been on a wild ride, plunging 21% from its high last September, but surging 22% in the last three months. Despite lagging behind the market year-to-date, strong Q2 earnings, product innovations, and bullish analyst ratings suggest a potential comeback. Is this a turnaround story in the making, or will competitors continue to outperform? Find out what's driving Thermo Fisher's stock and what investors should watch for. Hosted on Acast. See acast.com/privacy for more information.